Stakeholders want clearer terms in FDA's generally accepted scientific knowledge guidance
Regulatory NewsMary Ellen Schneider
Biologics/ biosimilars/ vaccinesPharmaceuticalsRegulatory NewsMary Ellen SchneiderBiologics/ biosimilars/ vaccinesPharmaceuticals